(Q52059435)

20 April 2018

title

Antifungal activity of histatin-5 against non-albicans Candida species. (English)

1 reference

20 April 2018

1 reference

Nikawa H

1

1 reference

20 April 2018

Jin C

2

1 reference

20 April 2018

Fukushima H

3

1 reference

20 April 2018

Makihira S

4

1 reference

20 April 2018

Hamada T

5

1 reference

20 April 2018

publication date

1 August 2001

1 reference

20 April 2018

Oral Microbiology and Immunology

published in

1 reference

20 April 2018

volume

16

1 reference

20 April 2018

issue

4

1 reference

20 April 2018

page(s)

250-252

1 reference

20 April 2018

Candidacidal activity of salivary histatins. Identification of a histatin 5-binding protein on Candida albicans

cites work

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.160409.X

Emergence of Candida parapsilosis as the predominant species causing candidemia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.160409.X

The effect of antifungal agents on the in vitro susceptibility of Candida albicans to apo-lactoferrin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.160409.X

In vitro assessment of antifungal therapeutic potential of salivary histatin-5, two variants of histatin-5, and salivary mucin (MUC7) domain 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.160409.X

Human salivary histatin-5 exerts potent fungicidal activity against Cryptococcus neoformans

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.160409.X

Importance of Candida species other than C. albicans as pathogens in oncology patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.160409.X

Amphotericin B- and fluconazole-resistant Candida spp., Aspergillus fumigatus, and other newly emerging pathogenic fungi are susceptible to basic antifungal peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.160409.X

7 January 2021

One-step purification of histidine-rich polypeptides form human parotid saliva and determination of anti-candidal activity

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.160409.X

7 January 2021

Longitudinal study of parotid saliva in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.160409.X

7 January 2021

Histatin as a synergistic stimulator with epidermal growth factor of rabbit chondrocyte proliferation

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.160409.X

7 January 2021

The fungicidal effect of human lactoferrin on Candida albicans and Candida krusei

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.160409.X

7 January 2021

An epidemiological study of Candida species infection in cancer patients using genetic fingerprinting and morphotyping

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.160409.X

7 January 2021

Antifungal activities of salivary histidine-rich polypeptides against Candida albicans and other oral yeast isolates

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.160409.X

7 January 2021

The emerging fungal threat

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.160409.X

7 January 2021

In vitro susceptibility of Candida species to lysozyme

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.160409.X

7 January 2021

Clinical, cellular, and molecular factors that contribute to antifungal drug resistance.

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.160409.X

7 January 2021

Anticandidal activity of major human salivary histatins

1 reference

https://api.crossref.org/works/10.1034%2FJ.1399-302X.2001.160409.X

7 January 2021

10.1034/J.1399-302X.2001.160409.X

Identifiers

DOI

1 reference

20 April 2018

1 reference

20 April 2018